Engineering Yarrowia lipolytica for the utilization of acid whey.
Metab Eng
; 57: 43-50, 2020 01.
Article
em En
| MEDLINE
| ID: mdl-31562926
Acid whey, a byproduct in cheese and yogurt production, demands high costs in disposal at large quantities. Nonetheless, it contains abundant sugars and nutrients that can potentially be utilized by microorganisms. Here we report a novel platform technology that converts acid whey into value-added products using Yarrowia lipolytica. Since wild type strains do not assimilate lactose, a major carbon source in whey, a secreted ß-galactosidase was introduced. Additionally, to accelerate galactose metabolism, we overexpressed the relevant native four genes of the Leloir pathway. The engineered strain could achieve rapid total conversion of all carbon sources in acid whey, producing 6.61â¯g/L of fatty acids (FAs) with a yield of 0.146â¯g-FAs/g-substrates. Further engineering to introduce an omega-3 desaturase enabled the synthesis of α-linolenic acid from acid whey, producing 10.5 mg/gDCW within a short fermentation time. Finally, PEX10 knockout in our platform strain was shown to minimize hyphal formation in concentrated acid whey cultures, greatly improving fatty acid content. These results demonstrate the feasibility of using acid whey as a previously untapped resource for biotechnology.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Yarrowia
/
Ácidos Graxos
/
Engenharia Metabólica
/
Soro do Leite
/
Microrganismos Geneticamente Modificados
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article